Related Experiment Video
Updated: May 8, 2026
05:13
Preclinical Model of Prenatal Delta-9-Tetrahydrocannabinol Exposure to Assess Its Impact on Neurodevelopmental Outcomes
Published on: February 28, 2025
Chronic opioid use during pregnancy: maternal and fetal implications
Todd J Stanhope1, Lisa A Gill, Carl Rose
1Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Mayo Clinic, 200 First Street SW, Rochester, MN 55902, USA.
Clinics in Perinatology
|August 27, 2013
Summary
Narcotic use in reproductive-aged women is rising, posing risks to both mothers and fetuses during pregnancy. Effective management requires individualized care, including potential substitution therapy and multidisciplinary support.
Area of Science:
- Obstetrics and Gynecology
- Maternal-Fetal Medicine
- Addiction Medicine
Background:
- Chronic narcotic use has significantly increased in reproductive-aged women in the U.S. over the last decade.
- Pregnancy exposure to narcotics presents substantial risks for maternal and fetal well-being.
- Optimal prenatal care is essential for managing pregnancies complicated by narcotic dependence.
Purpose of the Study:
- To review current trends in narcotic use among reproductive-aged women.
- To discuss the maternal and fetal risks associated with narcotic use during pregnancy.
- To outline management strategies for narcotic dependence throughout the antepartum, intrapartum, and postpartum periods.
Main Methods:
- Literature review of current trends and research on narcotic use in pregnancy.
- Analysis of maternal and fetal implications of chronic narcotic exposure.
- Synthesis of evidence-based management strategies for narcotic dependence in pregnant populations.
Main Results:
- Increased prevalence of chronic narcotic use in women of reproductive age.
- Significant maternal and fetal risks identified, necessitating careful monitoring.
- Various management options exist, including discontinuation, dose limitation, and substitution therapies like methadone and buprenorphine.
Conclusions:
- Patient-specific management plans are crucial for pregnant women with narcotic dependence.
- A multidisciplinary and collaborative approach enhances care outcomes.
- Comprehensive strategies are needed for antepartum, intrapartum, and postpartum management to mitigate risks.
Related Concept Videos
01:15Opioid Analgesics: Synthetic and Semisynthetic Opioids
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
01:20Opioid Analgesics: Morphine and Other Natural Cogeners
Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
01:25Analgesia and Pain Management
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
01:29Local Anesthetics: Clinical Application as Epidural Anesthesia
Epidural anesthetics are administered in the fat-filled epidural space, the outermost part of the spinal canal. This technique is commonly employed for pain management and anesthesia during lower abdomen and pelvis surgeries or labor and delivery.
Since epidural anesthetics can be infused through an epidural catheter, all types of drugs, including short-acting ones, can be administered. Chloroprocaine and lidocaine are examples of short and long-duration anesthetics, respectively. Bupivacaine...
Since epidural anesthetics can be infused through an epidural catheter, all types of drugs, including short-acting ones, can be administered. Chloroprocaine and lidocaine are examples of short and long-duration anesthetics, respectively. Bupivacaine...
01:22Opioid Receptors: Overview
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2, D-Pen5]-enkephalin or DPDPE for...
01:07Teratogenicity
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...